Portfolio Update

RNS Number : 7396R

Intl. Biotechnology Trust PLC

18 June 2018

 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC (the Company)

Portfolio Update as at 31 May 2018

Net Assets	£235m
Net Assets per share	626p
Share price	595p
Total value of unquoted investments	£23m
Total number of portfolio companies	78
Dividend	4% of NAV per annum

Top Ten Quoted Investments

Company Name	% NAV
Neurocrine	5.5
Celgene	4.8
Biogen	4.3
Vertex	4.1
Array	4.0
Illumina	3.9
Sage	3.9
Morphosys	3.7
Genmab	3.6
Adamas	3.4
	-----------
Total	41.2

Geographical Allocation	% NAV
US & Canada	86
Europe	14
	-----------
Total	100

Quoted/Unquoted Allocation	% NAV
Quoted	90
Unquoted	10
	-----------
Total	100

NAV % Market Cap	% NAV
Large Cap >USD10BN	35
Mid Cap =USD1-10BN	41
Small Cap <USD1BN	24
	-----------
Total	100

NAV % by Therapeutic Areas	% NAV
Oncology	43
CNS	16
Rare diseases	11
Inflammation	6
Ophthalmology	6
Infectious Diseases	3
Metabolic	3
Medtech	2
Other	10
	-----------
Total	100

BNP Paribas Secretarial Services Limited

Company Secretary

18 JUNE 2018

 

END

 

 

PFUBDGDLBDBBGII